IDIQ - TO - Human Pharm - Tobacco Use Study 7
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $3,000,000 to $7,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541618 Other Management Consulting Services
- Points of contact
-
- Ajmal Hussain ajmal.hussain@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting an Indefinite Delivery/Indefinite Quantity (IDIQ) task order for a Tobacco Use Study 7, classified under Other Management Consulting Services (NAICS 541618). The contract is expected to have a solicitation release on May 1, 2026, with an estimated award date of July 1, 2026, targeting research and consulting services related to human pharmaceutical aspects of tobacco use.
While specific award values and detailed contract specifics are not currently available, the procurement will be managed through the Department of Health and Human Services and does not have a specific small business set-aside. Potential vendors interested in this opportunity can contact Ajmal Hussain at ajmal.hussain@fda.hhs.gov for further information, with the expectation that this will be a federal government-managed consulting engagement focused on tobacco use research and analysis.
Forecast text
IDIQ - TO - Human Pharm - Tobacco Use Study 7
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast